- Home
- APGE vs MCRI Comparison
APGE vs MCRI Comparison
Compare APGE & MCRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- MCRI
- Stock Information
- Founded
- APGE 2022
- MCRI 1972
- Country
- APGE United States
- MCRI United States
- Employees
- APGE N/A
- MCRI N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- MCRI Hotels/Resorts
- Sector
- APGE Health Care
- MCRI Consumer Discretionary
- Exchange
- APGE Nasdaq
- MCRI Nasdaq
- Market Cap
- APGE 1.8B
- MCRI 1.5B
- IPO Year
- APGE 2023
- MCRI 1993
- Fundamental
- Price
- APGE $39.72
- MCRI $78.39
- Analyst Decision
- APGE Strong Buy
- MCRI Hold
- Analyst Count
- APGE 4
- MCRI 5
- Target Price
- APGE $91.33
- MCRI $87.20
- AVG Volume (30 Days)
- APGE 789.9K
- MCRI 117.9K
- Earning Date
- APGE 03-03-2025
- MCRI 04-16-2025
- Dividend Yield
- APGE N/A
- MCRI 1.53%
- EPS Growth
- APGE N/A
- MCRI N/A
- EPS
- APGE N/A
- MCRI 3.84
- Revenue
- APGE N/A
- MCRI $522,186,000.00
- Revenue This Year
- APGE N/A
- MCRI $3.88
- Revenue Next Year
- APGE $795.25
- MCRI $2.76
- P/E Ratio
- APGE N/A
- MCRI $20.41
- Revenue Growth
- APGE N/A
- MCRI 4.13
- 52 Week Low
- APGE $29.10
- MCRI $64.50
- 52 Week High
- APGE $68.21
- MCRI $96.11
- Technical
- Relative Strength Index (RSI)
- APGE 55.27
- MCRI 26.56
- Support Level
- APGE $38.18
- MCRI $79.17
- Resistance Level
- APGE $41.07
- MCRI $84.12
- Average True Range (ATR)
- APGE 2.31
- MCRI 2.47
- MACD
- APGE 0.22
- MCRI -0.52
- Stochastic Oscillator
- APGE 63.77
- MCRI 1.08
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About MCRI Monarch Casino & Resort Inc.
Monarch Casino & Resort Inc is engaged in providing the latest gaming, dining, and hospitality amenities. It owns and operates the Atlantis Casino Resort Spa, a hotel/casino facility in Reno, Nevada, and the Monarch Black Hawk Casino in Black Hawk. The company generates the majority of its revenue from Casinos, followed by Food & Beverage and Hotel Operations.